Kyntra Bio (KYNB) Work In Process (2018 - 2024)
Historic Work In Process for Kyntra Bio (KYNB) over the last 7 years, with Q4 2024 value amounting to $3.2 million.
- Kyntra Bio's Work In Process fell 8074.58% to $3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 million, marking a year-over-year decrease of 8074.58%. This contributed to the annual value of $3.2 million for FY2024, which is 8074.58% down from last year.
- According to the latest figures from Q4 2024, Kyntra Bio's Work In Process is $3.2 million, which was down 8074.58% from $17.8 million recorded in Q3 2024.
- In the past 5 years, Kyntra Bio's Work In Process registered a high of $37.3 million during Q1 2023, and its lowest value of $2.9 million during Q1 2020.
- Moreover, its 5-year median value for Work In Process was $20.0 million (2024), whereas its average is $20.6 million.
- As far as peak fluctuations go, Kyntra Bio's Work In Process surged by 30736.57% in 2021, and later tumbled by 8074.58% in 2024.
- Kyntra Bio's Work In Process (Quarter) stood at $8.1 million in 2020, then surged by 164.96% to $21.5 million in 2021, then soared by 67.46% to $36.0 million in 2022, then crashed by 54.49% to $16.4 million in 2023, then crashed by 80.75% to $3.2 million in 2024.
- Its Work In Process stands at $3.2 million for Q4 2024, versus $17.8 million for Q3 2024 and $19.5 million for Q2 2024.